Birendra’s project aims to characterize novel regulators of autophagy by leveraging yeast as a model organism. He joined the Enserink group in August 2025.
Andresen S, Al Outa A, Formica M, Enserink J, Knævelsrud H(2025) Improved detection of lipidated Atg8a by immunoblotting in Drosophila melanogaster cells and tissues enables precise investigation of Atg8a flux and its termination Autophagy, 1-21(in press) DOI 10.1080/15548627.2025.2508551, PubMed 40426043
Fuentes-Martín R, Ayuda-Durán P, Hanes R, Gallego-Yerga L, Wolterinck L, Enserink JM, Álvarez R, Peláez R(2024) Promising anti-proliferative indolic benzenesulfonamides alter mechanisms with sulfonamide nitrogen substituents Eur J Med Chem, 275, 116617 DOI 10.1016/j.ejmech.2024.116617, PubMed 38959729
Caulier B, Joaquina S, Gelebart P, Dowling TH, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NU, Wogsland C, Gjerstad ME, Fløisand Y, Kvalheim G, Marr C, Kobold S, Enserink JM, Gjertsen BT, McCormack E, Inderberg EM, Wälchli S(2024) CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia Cell Rep Med, 5(6), 101572 DOI 10.1016/j.xcrm.2024.101572, PubMed 38754420
Department of Molecular Cell Biology, Institute for Cancer Research The Norwegian Radium Hospital, Montebello, N-0379 Oslo, Norway Telephone +47 22 78 19 82 (Enserink), +47 22 78 12 69 (Dept. Secretary) Email: j.m.enserink@ibv.uio.no
